Healthy Living/WellnessFDA shows no love for Johnson & Johnson Xarelto blood thinner, rejects expanded use for 3rd time The FDA didn't show any love for Johnson & Johnson on Friday, Feb. 14, denying the pharmaceutical major's application for the expanded use of the anticoagulant drug Xarelto for the third time.by Randell Suba
Healthy Living/WellnessMade in India drugs come under FDA scanner over safety concernsby James Maynard
Healthy Living/WellnessFDA set to launch $115 million anti-tobacco ad campaign targeting teen smokersby Sumit Passary
Healthy Living/WellnessNutrition label makeover proposed by FDA will make it easier to understand and more usefulby Maryanne Moll
Healthy Living/WellnessThe caramel color in your cola may kill you, Consumer Reports warnsby Rhodilee Jean Dolor
Leader of Furry Hackers Raided by Feds Months After Attack on Creators of Project 2025, Former Member Claims